Related Experiment Videos
Rationalized assessment of prolonged jaundice is safe and cost-effective
1Neonatal Unit, Southern General Hospital, Glasgow, Scotland, UK. martina.rodie@nhs.net
Scottish Medical Journal
|August 4, 2012
Summary
A new guideline for prolonged jaundice (PJ) in newborns significantly reduced unnecessary appointments and tests. This approach is cost-effective but doesn't identify all cases of liver disease, suggesting population-based screening may be better.
Area of Science:
- Neonatal Medicine
- Pediatric Gastroenterology
- Clinical Auditing
Background:
- Prolonged jaundice (PJ) in healthy term neonates is common but can indicate serious liver disease.
- Current assessment methods for PJ show significant variation.
- A balanced approach is needed to avoid over-investigation while detecting pathology early.
Purpose of the Study:
- To audit the management of prolonged jaundice in neonatal units.
- To evaluate the impact of a rationalized investigation algorithm based on BSPGHAN guidelines.
- To assess the effectiveness and cost-efficiency of the new algorithm.
Main Methods:
- Prospective audit of PJ management over two years in two Level 3 neonatal units.
- Comparison of practice before and after implementing a standardized algorithm (clinical exam, stool inspection, split bilirubin).
- Inclusion of 197 neonates referred with PJ (105 pre-algorithm, 92 post-algorithm).
Main Results:
- No underlying liver pathology was identified in the studied neonates with PJ.
- The rationalized algorithm led to a significant reduction in return appointments (28 vs. 7) and repeat investigations (37 vs. 7).
- Cost savings of £1575-£2625 annually in laboratory costs were observed.
Conclusions:
- A rationalized approach to assessing prolonged jaundice is effective, reduces workload, and is cost-effective.
- Selective screening for PJ has limitations, as evidenced by three infants with biliary atresia diagnosed late.
- Population-based screening methods warrant further consideration for identifying cholestatic liver disease.
Related Concept Videos
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...